Business Wire

Joint Cross-industry Statement: Cement Industry Co-Processing Should Be More Widely Adopted for Global Sustainable Waste Management

14.1.2026 15:00:00 CET | Business Wire | Press Release

Share

Leading industry organisations today issued a joint statement highlighting the substantial and positive contribution the cement industry can make to addressing the urgent global challenge of non-recyclable and non-reusable waste. The Global Cement and Concrete Association – GCCA; European Composites Industry Association (EuCIA); International Solid Waste Association – Africa; Mission Possible Partnership; and The Global Waste-to-Energy Research and Technology Council – WtERT® are calling for stronger policy support to unlock the full potential of cement industry co-processing as a safe, effective and sustainable global waste management solution.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114232332/en/

Co-processing enables both energy recovery and material recycling. It uses waste to replace fossil fuels in heating cement kilns, while any remaining ashes are simultaneously recycled into the building material compound itself, making it a zero-waste solution. This integrated process maximises the environmental value of waste treatment and lowers the demand for new disposal infrastructure. Co-processing focuses on waste streams that cannot be recycled or are contaminated and as such is complementary to recycling. Co-processing creates a bridge between landfilling and recycling.

Co-processing is already recognised globally, from Europe and India to Latin America and North America, as an environmentally sound waste management practice. It operates under strict regulatory frameworks and technical guidelines to ensure high standards of safety, emissions control, and transparency.

Thomas Guillot, Chief Executive of the GCCA said: “Cement industry co-processing is a safe, effective and circular waste management solution - a win-win for the environment and local communities. However, despite its proven benefits, wider adoption of co-processing depends on effective regulatory frameworks and supportive public policy.

“Some cement kilns already substitute more than 90% of fuels with waste through co-processing, whereas many parts of the world have no established practises at all. That is why we are renewing our efforts along with other organisations and calling for recognition and support of our industry’s positive role and potential.”

The joint statement calls on international institutions and national, regional, and municipal governments to:

  • Recognise co-processing in waste policy frameworks as a sustainable waste management solution that delivers both energy recovery and material recycling;
  • Incentivise waste collection, sorting, and pre-treatment at municipal level to ensure consistent, high-quality waste streams, encouraging recycling of the recyclable material and the co-processing of non-recyclable material
  • Enable efficient environmental permitting to allow cement plants access to suitable waste;
  • Count the materials’ content (ash) effectively recycled through co-processing towards national recycling targets;
  • Provide fiscal incentives acknowledging the environmental benefits of co-processing waste in a cement kiln to create a level playing field with other waste management and energy options;
  • Foster public-private partnerships to share risk and support long-term project viability;
  • Encourage knowledge transfer and policy alignment across regions.

A Growing Global Challenge

Waste generated by human and industrial activity is estimated at 11.2 billion tonnes annually, with the decomposition of organic solid waste contributing around 5% of global greenhouse gas emissions, plastics creating micro-plastics pollution and leaching of hazardous substances According to the United Nations Environment Programme, uncontrolled municipal solid waste could double to 1.6 billion tonnes by 2050 if current practices continue. This trajectory will further intensify climate change, marine plastic pollution, and adverse health impacts worldwide.

Thomas Guillot added: “Waste generation and mismanagement are placing growing pressure on communities, ecosystems, and the global climate. When waste is dumped in streets, openly burned, or leaks into rivers and oceans, it causes severe environmental damage and poses serious health risks. Even in regions with waste management systems, large volumes of waste continue to end up in landfills, where biological and chemical degradation contaminates soil and releases methane, a greenhouse gas significantly more potent than carbon dioxide.”

Transforming Waste into Purpose

Signatories to the joint statement believe that co-processing represents a practical, scalable and sustainable response to the global waste challenge. With the right policy support it can help divert waste from being irresponsibly discarded, buried in landfills, reduce fossil fuel use in the cement industry and transform waste into a valuable resource for society.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260114232332/en/

Contacts

Paul Adeleke
paul.adeleke@gccassociation.org

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye